HLEMX | RNWHX | HLEMX / RNWHX | |
Total Expense Ratio | 1.14 | 0.72 | 158% |
Annual Report Gross Expense Ratio | 1.14 | 0.72 | 158% |
Fund Existence | 27 years | 10 years | - |
Gain YTD | 11.932 | 15.785 | 76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 250 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 428M | 69.9B | 1% |
Annual Yield % from dividends | 1.45 | 0.99 | 147% |
Returns for 1 year | 0.96 | 12.22 | 8% |
Returns for 3 years | -4.80 | 39.15 | -12% |
Returns for 5 years | -18.85 | 31.70 | -59% |
Returns for 10 years | -6.78 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 59.43 | 1.07 | +1.83% |
Virtus LifeSci Biotech Products ETF | |||
GNOV | 36.55 | 0.12 | +0.34% |
FT Vest U.S. Eq Mod Buffr ETF - Nov | |||
IMCG | 80.46 | 0.27 | +0.34% |
iShares Morningstar Mid-Cap Growth ETF | |||
OCTM | 31.43 | 0.02 | +0.08% |
FT Vest U.S. Equity Max Buffer ETF – Oct | |||
CXE | 3.58 | -0.02 | -0.56% |
MFS High Income Municipal Trust |